Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP899052.RA13DfUyJiQV3UqM-FEkzbElyfRpfKw5WoP50tlA-VMyA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP899052.RA13DfUyJiQV3UqM-FEkzbElyfRpfKw5WoP50tlA-VMyA130_assertion type Assertion NP899052.RA13DfUyJiQV3UqM-FEkzbElyfRpfKw5WoP50tlA-VMyA130_head.
- NP899052.RA13DfUyJiQV3UqM-FEkzbElyfRpfKw5WoP50tlA-VMyA130_assertion wasGeneratedBy ECO_0000203 NP899052.RA13DfUyJiQV3UqM-FEkzbElyfRpfKw5WoP50tlA-VMyA130_provenance.
- NP899052.RA13DfUyJiQV3UqM-FEkzbElyfRpfKw5WoP50tlA-VMyA130_assertion wasDerivedFrom befree-20140225 NP899052.RA13DfUyJiQV3UqM-FEkzbElyfRpfKw5WoP50tlA-VMyA130_provenance.
- NP899052.RA13DfUyJiQV3UqM-FEkzbElyfRpfKw5WoP50tlA-VMyA130_assertion SIO_000772 17295209 NP899052.RA13DfUyJiQV3UqM-FEkzbElyfRpfKw5WoP50tlA-VMyA130_provenance.
- NP899052.RA13DfUyJiQV3UqM-FEkzbElyfRpfKw5WoP50tlA-VMyA130_assertion evidence source_evidence_literature NP899052.RA13DfUyJiQV3UqM-FEkzbElyfRpfKw5WoP50tlA-VMyA130_provenance.
- NP899052.RA13DfUyJiQV3UqM-FEkzbElyfRpfKw5WoP50tlA-VMyA130_assertion description "[Prior inactivation of PARP protected both cell lines from the initial decrease in NAD+ and improved the survival of LNCaP cells following combined EGF and IR treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP899052.RA13DfUyJiQV3UqM-FEkzbElyfRpfKw5WoP50tlA-VMyA130_provenance.